Please Wait.....
Report
Single Cell Analysis Market By Product (Consumables, Instruments), By Techniques (Flow Cytometry, Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Mass Spectrometry, Others), By End User (Academic and Research Laboratories, Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, Others), By Application (Oncology, Immunology, Neurology, Stem cell, Non-Invasive Prenatal Diagnosis, In-Vitro Fertilization (IVF), Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
Market Report I 2022-07-01 I 270 Pages I Allied Market Research
The global single cell analysis market was valued at $2,641.5 million in 2021, and is projected to reach $13,616.76 million by 2031, registering a CAGR of 17.8% from 2022 to 2031.
Single-cell analysis (SCA) is essential in order to show population heterogeneity, identify minority sub-populations of interest, and learn about the particular traits of individual cells. Microfluidic systems are useful for manipulating single cells since they operate at a scale similar to cell diameter. A microfluidic array capable of quickly and deterministically trapping individual cells in densely packed microwells. This trapping array can be linked with multiple microfluidic sample processing units with variable flow rates for various single-cell studies because the single-cell trapping efficiency is dictated by the channel design rather than the flow rate. SCA is also commonly used in plant biology, prenatal diagnostics, microbiology, immunology, and neuroscience.
The major factors that drive the growth of the global single cell analysis market include technological advancement in single cell analysis and increase in R&D in pharmaceutical and biotechnology industry. In addition, growth in stem cell research, growing focus on personalized medicines and surge in prevalence of cancer further propel the market growth. However, high cost of single cell analysis products is expected to restrain the growth of the single cell analysis market during the forecast period. Conversely, high growth potential of single cell sequencing is anticipated to provide lucrative opportunities to the market players.
The single cell analysis market is segmented into product, application, techniques, end user and region. According to product, the market is categorized into consumables and instruments. By application, it is segregated into oncology, immunology, neurology, stem cell, non-invasive prenatal diagnosis, In-vitro fertilization, others. According to techniques, the market is categorized into flow cytometry, next generation sequencing, polymerase chain reaction, mass spectrometry and others. On the basis of end user, it is segmented into academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include the Becton, Dickinson and Company, Danaher Corporation, Merck KGAA, QIAGEN N.V., Thermo Fisher Scientific, Inc., 10x Genomics, Illumina, Inc., Bio-Rad Laboratories, Agilent Technologies, Inc., Sartorius AG, Takara Holdingsinc, Oxford Nanopore Technologies., Berkley Light INC., BGI Genomics Co.Ltd., Diasorin Group, Dolomite Bio, Standard Biotools.
Key Benefits For Stakeholders
-This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the single cell analysis market analysis from 2021 to 2031 to identify the prevailing single cell analysis market opportunities.
-The market research is offered along with information related to key drivers, restraints, and opportunities.
-Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
-In-depth analysis of the single cell analysis market segmentation assists to determine the prevailing market opportunities.
-Major countries in each region are mapped according to their revenue contribution to the global market.
-Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
-The report includes the analysis of the regional as well as global single cell analysis market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
- Consumables
- Instruments
By Techniques
- Flow Cytometry
- Next Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Mass Spectrometry
- Others
By End User
- Academic and Research Laboratories
- Biotechnology and Pharmaceutical Companies
- Hospitals and Diagnostic Laboratories
- Others
By Application
- Oncology
- Immunology
- Neurology
- Stem cell
- Non-Invasive Prenatal Diagnosis
- In-Vitro Fertilization (IVF)
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- 10x Genomics
- Agilent Technologies, Inc.
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Danaher Corporation(Cytiva Life Sciences)
- Illumina, Inc.
- BERKLEY LIGHTS INC
- BGI GENOMICS CO. LTD
- DIASORIN GROUP (LUMINEX CORPORATION)
- DOLOMITE BIO
- MERCK KGAA
- OXFORD NANAOPORE TECHNOLOGIES
- QIAGEN N.V
- Sartorius AG
- STANDARD BIOTOOLS (Fluidigm Corporation)
- TAKARA HOLDINGS INC
- THERMO FISHER SCIENTIFIC, INC.
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: SINGLE CELL ANALYSIS MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Consumables
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Instruments
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: SINGLE CELL ANALYSIS MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Oncology
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Immunology
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Neurology
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Stem cell
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
5.6 Non-Invasive Prenatal Diagnosis
5.6.1 Key market trends, growth factors and opportunities
5.6.2 Market size and forecast, by region
5.6.3 Market analysis by country
5.7 In-Vitro Fertilization (IVF)
5.7.1 Key market trends, growth factors and opportunities
5.7.2 Market size and forecast, by region
5.7.3 Market analysis by country
5.8 Others
5.8.1 Key market trends, growth factors and opportunities
5.8.2 Market size and forecast, by region
5.8.3 Market analysis by country
CHAPTER 6: SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES
6.1 Overview
6.1.1 Market size and forecast
6.2 Flow Cytometry
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Next Generation Sequencing (NGS)
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Polymerase Chain Reaction (PCR)
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Mass Spectrometry
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
6.6 Others
6.6.1 Key market trends, growth factors and opportunities
6.6.2 Market size and forecast, by region
6.6.3 Market analysis by country
CHAPTER 7: SINGLE CELL ANALYSIS MARKET, BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Academic and Research Laboratories
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Biotechnology and Pharmaceutical Companies
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Hospitals and Diagnostic Laboratories
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country
7.5 Others
7.5.1 Key market trends, growth factors and opportunities
7.5.2 Market size and forecast, by region
7.5.3 Market analysis by country
CHAPTER 8: SINGLE CELL ANALYSIS MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Product
8.2.3 North America Market size and forecast, by Application
8.2.4 North America Market size and forecast, by Techniques
8.2.5 North America Market size and forecast, by End User
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Product
8.2.6.1.2 Market size and forecast, by Application
8.2.6.1.3 Market size and forecast, by Techniques
8.2.6.1.4 Market size and forecast, by End User
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Product
8.2.6.2.2 Market size and forecast, by Application
8.2.6.2.3 Market size and forecast, by Techniques
8.2.6.2.4 Market size and forecast, by End User
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Product
8.2.6.3.2 Market size and forecast, by Application
8.2.6.3.3 Market size and forecast, by Techniques
8.2.6.3.4 Market size and forecast, by End User
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Product
8.3.3 Europe Market size and forecast, by Application
8.3.4 Europe Market size and forecast, by Techniques
8.3.5 Europe Market size and forecast, by End User
8.3.6 Europe Market size and forecast, by country
8.3.6.1 Germany
8.3.6.1.1 Market size and forecast, by Product
8.3.6.1.2 Market size and forecast, by Application
8.3.6.1.3 Market size and forecast, by Techniques
8.3.6.1.4 Market size and forecast, by End User
8.3.6.2 France
8.3.6.2.1 Market size and forecast, by Product
8.3.6.2.2 Market size and forecast, by Application
8.3.6.2.3 Market size and forecast, by Techniques
8.3.6.2.4 Market size and forecast, by End User
8.3.6.3 U.K.
8.3.6.3.1 Market size and forecast, by Product
8.3.6.3.2 Market size and forecast, by Application
8.3.6.3.3 Market size and forecast, by Techniques
8.3.6.3.4 Market size and forecast, by End User
8.3.6.4 Italy
8.3.6.4.1 Market size and forecast, by Product
8.3.6.4.2 Market size and forecast, by Application
8.3.6.4.3 Market size and forecast, by Techniques
8.3.6.4.4 Market size and forecast, by End User
8.3.6.5 Spain
8.3.6.5.1 Market size and forecast, by Product
8.3.6.5.2 Market size and forecast, by Application
8.3.6.5.3 Market size and forecast, by Techniques
8.3.6.5.4 Market size and forecast, by End User
8.3.6.6 Rest of Europe
8.3.6.6.1 Market size and forecast, by Product
8.3.6.6.2 Market size and forecast, by Application
8.3.6.6.3 Market size and forecast, by Techniques
8.3.6.6.4 Market size and forecast, by End User
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Product
8.4.3 Asia-Pacific Market size and forecast, by Application
8.4.4 Asia-Pacific Market size and forecast, by Techniques
8.4.5 Asia-Pacific Market size and forecast, by End User
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 Japan
8.4.6.1.1 Market size and forecast, by Product
8.4.6.1.2 Market size and forecast, by Application
8.4.6.1.3 Market size and forecast, by Techniques
8.4.6.1.4 Market size and forecast, by End User
8.4.6.2 China
8.4.6.2.1 Market size and forecast, by Product
8.4.6.2.2 Market size and forecast, by Application
8.4.6.2.3 Market size and forecast, by Techniques
8.4.6.2.4 Market size and forecast, by End User
8.4.6.3 India
8.4.6.3.1 Market size and forecast, by Product
8.4.6.3.2 Market size and forecast, by Application
8.4.6.3.3 Market size and forecast, by Techniques
8.4.6.3.4 Market size and forecast, by End User
8.4.6.4 Australia
8.4.6.4.1 Market size and forecast, by Product
8.4.6.4.2 Market size and forecast, by Application
8.4.6.4.3 Market size and forecast, by Techniques
8.4.6.4.4 Market size and forecast, by End User
8.4.6.5 South Korea
8.4.6.5.1 Market size and forecast, by Product
8.4.6.5.2 Market size and forecast, by Application
8.4.6.5.3 Market size and forecast, by Techniques
8.4.6.5.4 Market size and forecast, by End User
8.4.6.6 Rest of Asia-Pacific
8.4.6.6.1 Market size and forecast, by Product
8.4.6.6.2 Market size and forecast, by Application
8.4.6.6.3 Market size and forecast, by Techniques
8.4.6.6.4 Market size and forecast, by End User
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Product
8.5.3 LAMEA Market size and forecast, by Application
8.5.4 LAMEA Market size and forecast, by Techniques
8.5.5 LAMEA Market size and forecast, by End User
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Brazil
8.5.6.1.1 Market size and forecast, by Product
8.5.6.1.2 Market size and forecast, by Application
8.5.6.1.3 Market size and forecast, by Techniques
8.5.6.1.4 Market size and forecast, by End User
8.5.6.2 Saudi Arabia
8.5.6.2.1 Market size and forecast, by Product
8.5.6.2.2 Market size and forecast, by Application
8.5.6.2.3 Market size and forecast, by Techniques
8.5.6.2.4 Market size and forecast, by End User
8.5.6.3 South Africa
8.5.6.3.1 Market size and forecast, by Product
8.5.6.3.2 Market size and forecast, by Application
8.5.6.3.3 Market size and forecast, by Techniques
8.5.6.3.4 Market size and forecast, by End User
8.5.6.4 Rest of LAMEA
8.5.6.4.1 Market size and forecast, by Product
8.5.6.4.2 Market size and forecast, by Application
8.5.6.4.3 Market size and forecast, by Techniques
8.5.6.4.4 Market size and forecast, by End User
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1 10x Genomics
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 Agilent Technologies, Inc.
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Becton, Dickinson and Company
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 Bio-Rad Laboratories
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 Danaher Corporation(Cytiva Life Sciences)
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Illumina, Inc.
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 BERKLEY LIGHTS INC
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 BGI GENOMICS CO. LTD
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 DIASORIN GROUP (LUMINEX CORPORATION)
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 DOLOMITE BIO
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments
10.11 MERCK KGAA
10.11.1 Company overview
10.11.2 Company snapshot
10.11.3 Operating business segments
10.11.4 Product portfolio
10.11.5 Business performance
10.11.6 Key strategic moves and developments
10.12 OXFORD NANAOPORE TECHNOLOGIES
10.12.1 Company overview
10.12.2 Company snapshot
10.12.3 Operating business segments
10.12.4 Product portfolio
10.12.5 Business performance
10.12.6 Key strategic moves and developments
10.13 QIAGEN N.V
10.13.1 Company overview
10.13.2 Company snapshot
10.13.3 Operating business segments
10.13.4 Product portfolio
10.13.5 Business performance
10.13.6 Key strategic moves and developments
10.14 Sartorius AG
10.14.1 Company overview
10.14.2 Company snapshot
10.14.3 Operating business segments
10.14.4 Product portfolio
10.14.5 Business performance
10.14.6 Key strategic moves and developments
10.15 STANDARD BIOTOOLS (Fluidigm Corporation)
10.15.1 Company overview
10.15.2 Company snapshot
10.15.3 Operating business segments
10.15.4 Product portfolio
10.15.5 Business performance
10.15.6 Key strategic moves and developments
10.16 TAKARA HOLDINGS INC
10.16.1 Company overview
10.16.2 Company snapshot
10.16.3 Operating business segments
10.16.4 Product portfolio
10.16.5 Business performance
10.16.6 Key strategic moves and developments
10.17 THERMO FISHER SCIENTIFIC, INC.
10.17.1 Company overview
10.17.2 Company snapshot
10.17.3 Operating business segments
10.17.4 Product portfolio
10.17.5 Business performance
10.17.6 Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 2. SINGLE CELL ANALYSIS MARKET SIZE, FOR CONSUMABLES, BY REGION, 2021-2031 ($MILLION)
TABLE 3. SINGLE CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. SINGLE CELL ANALYSIS MARKET SIZE, FOR INSTRUMENTS, BY REGION, 2021-2031 ($MILLION)
TABLE 5. SINGLE CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 6. GLOBAL SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 7. SINGLE CELL ANALYSIS MARKET SIZE, FOR ONCOLOGY, BY REGION, 2021-2031 ($MILLION)
TABLE 8. SINGLE CELL ANALYSIS MARKET FOR ONCOLOGY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 9. SINGLE CELL ANALYSIS MARKET SIZE, FOR IMMUNOLOGY, BY REGION, 2021-2031 ($MILLION)
TABLE 10. SINGLE CELL ANALYSIS MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 11. SINGLE CELL ANALYSIS MARKET SIZE, FOR NEUROLOGY, BY REGION, 2021-2031 ($MILLION)
TABLE 12. SINGLE CELL ANALYSIS MARKET FOR NEUROLOGY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 13. SINGLE CELL ANALYSIS MARKET SIZE, FOR STEM CELL, BY REGION, 2021-2031 ($MILLION)
TABLE 14. SINGLE CELL ANALYSIS MARKET FOR STEM CELL, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 15. SINGLE CELL ANALYSIS MARKET SIZE, FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY REGION, 2021-2031 ($MILLION)
TABLE 16. SINGLE CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 17. SINGLE CELL ANALYSIS MARKET SIZE, FOR IN-VITRO FERTILIZATION (IVF), BY REGION, 2021-2031 ($MILLION)
TABLE 18. SINGLE CELL ANALYSIS MARKET FOR IN-VITRO FERTILIZATION (IVF), BY COUNTRY, 2021-2031 ($MILLION)
TABLE 19. SINGLE CELL ANALYSIS MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 20. SINGLE CELL ANALYSIS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 21. GLOBAL SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 22. SINGLE CELL ANALYSIS MARKET SIZE, FOR FLOW CYTOMETRY, BY REGION, 2021-2031 ($MILLION)
TABLE 23. SINGLE CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 24. SINGLE CELL ANALYSIS MARKET SIZE, FOR NEXT GENERATION SEQUENCING (NGS), BY REGION, 2021-2031 ($MILLION)
TABLE 25. SINGLE CELL ANALYSIS MARKET FOR NEXT GENERATION SEQUENCING (NGS), BY COUNTRY, 2021-2031 ($MILLION)
TABLE 26. SINGLE CELL ANALYSIS MARKET SIZE, FOR POLYMERASE CHAIN REACTION (PCR), BY REGION, 2021-2031 ($MILLION)
TABLE 27. SINGLE CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION (PCR), BY COUNTRY, 2021-2031 ($MILLION)
TABLE 28. SINGLE CELL ANALYSIS MARKET SIZE, FOR MASS SPECTROMETRY, BY REGION, 2021-2031 ($MILLION)
TABLE 29. SINGLE CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 30. SINGLE CELL ANALYSIS MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 31. SINGLE CELL ANALYSIS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 32. GLOBAL SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 33. SINGLE CELL ANALYSIS MARKET SIZE, FOR ACADEMIC AND RESEARCH LABORATORIES, BY REGION, 2021-2031 ($MILLION)
TABLE 34. SINGLE CELL ANALYSIS MARKET FOR ACADEMIC AND RESEARCH LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 35. SINGLE CELL ANALYSIS MARKET SIZE, FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2021-2031 ($MILLION)
TABLE 36. SINGLE CELL ANALYSIS MARKET FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 37. SINGLE CELL ANALYSIS MARKET SIZE, FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2021-2031 ($MILLION)
TABLE 38. SINGLE CELL ANALYSIS MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 39. SINGLE CELL ANALYSIS MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 40. SINGLE CELL ANALYSIS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 41. SINGLE CELL ANALYSIS MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 42. NORTH AMERICA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 43. NORTH AMERICA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 44. NORTH AMERICA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 45. NORTH AMERICA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 46. NORTH AMERICA SINGLE CELL ANALYSIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 47. U.S. SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 48. U.S. SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 49. U.S. SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 50. U.S. SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 51. CANADA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 52. CANADA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 53. CANADA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 54. CANADA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 55. MEXICO SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 56. MEXICO SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 57. MEXICO SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 58. MEXICO SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 59. EUROPE SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 60. EUROPE SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 61. EUROPE SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 62. EUROPE SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 63. EUROPE SINGLE CELL ANALYSIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 64. GERMANY SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 65. GERMANY SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 66. GERMANY SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 67. GERMANY SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 68. FRANCE SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 69. FRANCE SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 70. FRANCE SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 71. FRANCE SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 72. U.K. SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 73. U.K. SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 74. U.K. SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 75. U.K. SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 76. ITALY SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 77. ITALY SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 78. ITALY SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 79. ITALY SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 80. SPAIN SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 81. SPAIN SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 82. SPAIN SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 83. SPAIN SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 84. REST OF EUROPE SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 85. REST OF EUROPE SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 86. REST OF EUROPE SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 87. REST OF EUROPE SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 88. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 89. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 90. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 91. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 92. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 93. JAPAN SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 94. JAPAN SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 95. JAPAN SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 96. JAPAN SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 97. CHINA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 98. CHINA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 99. CHINA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 100. CHINA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 101. INDIA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 102. INDIA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 103. INDIA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 104. INDIA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 105. AUSTRALIA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 106. AUSTRALIA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 107. AUSTRALIA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 108. AUSTRALIA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 109. SOUTH KOREA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 110. SOUTH KOREA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 111. SOUTH KOREA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 112. SOUTH KOREA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 113. REST OF ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 114. REST OF ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 115. REST OF ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 116. REST OF ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 117. LAMEA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 118. LAMEA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 119. LAMEA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 120. LAMEA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 121. LAMEA SINGLE CELL ANALYSIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 122. BRAZIL SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 123. BRAZIL SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 124. BRAZIL SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 125. BRAZIL SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 126. SAUDI ARABIA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 127. SAUDI ARABIA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 128. SAUDI ARABIA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 129. SAUDI ARABIA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 130. SOUTH AFRICA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 131. SOUTH AFRICA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 132. SOUTH AFRICA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 133. SOUTH AFRICA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 134. REST OF LAMEA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 135. REST OF LAMEA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 136. REST OF LAMEA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 137. REST OF LAMEA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 138.10X GENOMICS: COMPANY SNAPSHOT
TABLE 139.10X GENOMICS: OPERATING SEGMENTS
TABLE 140.10X GENOMICS: PRODUCT PORTFOLIO
TABLE 141.10X GENOMICS: NET SALES,
TABLE 142.10X GENOMICS: KEY STRATERGIES
TABLE 143.AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
TABLE 144.AGILENT TECHNOLOGIES, INC.: OPERATING SEGMENTS
TABLE 145.AGILENT TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
TABLE 146.AGILENT TECHNOLOGIES, INC.: NET SALES,
TABLE 147.AGILENT TECHNOLOGIES, INC.: KEY STRATERGIES
TABLE 148.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 149.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
TABLE 150.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 151.BECTON, DICKINSON AND COMPANY: NET SALES,
TABLE 152.BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
TABLE 153.BIO-RAD LABORATORIES: COMPANY SNAPSHOT
TABLE 154.BIO-RAD LABORATORIES: OPERATING SEGMENTS
TABLE 155.BIO-RAD LABORATORIES: PRODUCT PORTFOLIO
TABLE 156.BIO-RAD LABORATORIES: NET SALES,
TABLE 157.BIO-RAD LABORATORIES: KEY STRATERGIES
TABLE 158.DANAHER CORPORATION(CYTIVA LIFE SCIENCES): COMPANY SNAPSHOT
TABLE 159.DANAHER CORPORATION(CYTIVA LIFE SCIENCES): OPERATING SEGMENTS
TABLE 160.DANAHER CORPORATION(CYTIVA LIFE SCIENCES): PRODUCT PORTFOLIO
TABLE 161.DANAHER CORPORATION(CYTIVA LIFE SCIENCES): NET SALES,
TABLE 162.DANAHER CORPORATION(CYTIVA LIFE SCIENCES): KEY STRATERGIES
TABLE 163.ILLUMINA, INC.: COMPANY SNAPSHOT
TABLE 164.ILLUMINA, INC.: OPERATING SEGMENTS
TABLE 165.ILLUMINA, INC.: PRODUCT PORTFOLIO
TABLE 166.ILLUMINA, INC.: NET SALES,
TABLE 167.ILLUMINA, INC.: KEY STRATERGIES
TABLE 168.BERKLEY LIGHTS INC: COMPANY SNAPSHOT
TABLE 169.BERKLEY LIGHTS INC: OPERATING SEGMENTS
TABLE 170.BERKLEY LIGHTS INC: PRODUCT PORTFOLIO
TABLE 171.BERKLEY LIGHTS INC: NET SALES,
TABLE 172.BERKLEY LIGHTS INC: KEY STRATERGIES
TABLE 173.BGI GENOMICS CO. LTD: COMPANY SNAPSHOT
TABLE 174.BGI GENOMICS CO. LTD: OPERATING SEGMENTS
TABLE 175.BGI GENOMICS CO. LTD: PRODUCT PORTFOLIO
TABLE 176.BGI GENOMICS CO. LTD: NET SALES,
TABLE 177.BGI GENOMICS CO. LTD: KEY STRATERGIES
TABLE 178.DIASORIN GROUP (LUMINEX CORPORATION): COMPANY SNAPSHOT
TABLE 179.DIASORIN GROUP (LUMINEX CORPORATION): OPERATING SEGMENTS
TABLE 180.DIASORIN GROUP (LUMINEX CORPORATION): PRODUCT PORTFOLIO
TABLE 181.DIASORIN GROUP (LUMINEX CORPORATION): NET SALES,
TABLE 182.DIASORIN GROUP (LUMINEX CORPORATION): KEY STRATERGIES
TABLE 183.DOLOMITE BIO: COMPANY SNAPSHOT
TABLE 184.DOLOMITE BIO: OPERATING SEGMENTS
TABLE 185.DOLOMITE BIO: PRODUCT PORTFOLIO
TABLE 186.DOLOMITE BIO: NET SALES,
TABLE 187.DOLOMITE BIO: KEY STRATERGIES
TABLE 188.MERCK KGAA: COMPANY SNAPSHOT
TABLE 189.MERCK KGAA: OPERATING SEGMENTS
TABLE 190.MERCK KGAA: PRODUCT PORTFOLIO
TABLE 191.MERCK KGAA: NET SALES,
TABLE 192.MERCK KGAA: KEY STRATERGIES
TABLE 193.OXFORD NANAOPORE TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 194.OXFORD NANAOPORE TECHNOLOGIES: OPERATING SEGMENTS
TABLE 195.OXFORD NANAOPORE TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 196.OXFORD NANAOPORE TECHNOLOGIES: NET SALES,
TABLE 197.OXFORD NANAOPORE TECHNOLOGIES: KEY STRATERGIES
TABLE 198.QIAGEN N.V: COMPANY SNAPSHOT
TABLE 199.QIAGEN N.V: OPERATING SEGMENTS
TABLE 200.QIAGEN N.V: PRODUCT PORTFOLIO
TABLE 201.QIAGEN N.V: NET SALES,
TABLE 202.QIAGEN N.V: KEY STRATERGIES
TABLE 203.SARTORIUS AG: COMPANY SNAPSHOT
TABLE 204.SARTORIUS AG: OPERATING SEGMENTS
TABLE 205.SARTORIUS AG: PRODUCT PORTFOLIO
TABLE 206.SARTORIUS AG: NET SALES,
TABLE 207.SARTORIUS AG: KEY STRATERGIES
TABLE 208.STANDARD BIOTOOLS (FLUIDIGM CORPORATION): COMPANY SNAPSHOT
TABLE 209.STANDARD BIOTOOLS (FLUIDIGM CORPORATION): OPERATING SEGMENTS
TABLE 210.STANDARD BIOTOOLS (FLUIDIGM CORPORATION): PRODUCT PORTFOLIO
TABLE 211.STANDARD BIOTOOLS (FLUIDIGM CORPORATION): NET SALES,
TABLE 212.STANDARD BIOTOOLS (FLUIDIGM CORPORATION): KEY STRATERGIES
TABLE 213.TAKARA HOLDINGS INC: COMPANY SNAPSHOT
TABLE 214.TAKARA HOLDINGS INC: OPERATING SEGMENTS
TABLE 215.TAKARA HOLDINGS INC: PRODUCT PORTFOLIO
TABLE 216.TAKARA HOLDINGS INC: NET SALES,
TABLE 217.TAKARA HOLDINGS INC: KEY STRATERGIES
TABLE 218.THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
TABLE 219.THERMO FISHER SCIENTIFIC, INC.: OPERATING SEGMENTS
TABLE 220.THERMO FISHER SCIENTIFIC, INC.: PRODUCT PORTFOLIO
TABLE 221.THERMO FISHER SCIENTIFIC, INC.: NET SALES,
TABLE 222.THERMO FISHER SCIENTIFIC, INC.: KEY STRATERGIES
LIST OF FIGURES
FIGURE 1.SINGLE CELL ANALYSIS MARKET SEGMENTATION
FIGURE 2.SINGLE CELL ANALYSIS MARKET,2021-2031
FIGURE 3.SINGLE CELL ANALYSIS MARKET,2021-2031
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.SINGLE CELL ANALYSIS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.SINGLE CELL ANALYSIS MARKET,BY PRODUCT,2021(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF CONSUMABLES SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF INSTRUMENTS SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 15.SINGLE CELL ANALYSIS MARKET,BY APPLICATION,2021(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF ONCOLOGY SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF IMMUNOLOGY SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF NEUROLOGY SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF STEM CELL SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF NON-INVASIVE PRENATAL DIAGNOSIS SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF IN-VITRO FERTILIZATION (IVF) SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF OTHERS SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 23.SINGLE CELL ANALYSIS MARKET,BY TECHNIQUES,2021(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF FLOW CYTOMETRY SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 25.COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING (NGS) SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 26.COMPARATIVE SHARE ANALYSIS OF POLYMERASE CHAIN REACTION (PCR) SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 27.COMPARATIVE SHARE ANALYSIS OF MASS SPECTROMETRY SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 28.COMPARATIVE SHARE ANALYSIS OF OTHERS SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 29.SINGLE CELL ANALYSIS MARKET,BY END USER,2021(%)
FIGURE 30.COMPARATIVE SHARE ANALYSIS OF ACADEMIC AND RESEARCH LABORATORIES SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 31.COMPARATIVE SHARE ANALYSIS OF BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 32.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND DIAGNOSTIC LABORATORIES SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 33.COMPARATIVE SHARE ANALYSIS OF OTHERS SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 34.SINGLE CELL ANALYSIS MARKET BY REGION,2021
FIGURE 35.U.S. SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 36.CANADA SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 37.MEXICO SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 38.GERMANY SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 39.FRANCE SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 40.U.K. SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 41.ITALY SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 42.SPAIN SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 43.REST OF EUROPE SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 44.JAPAN SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 45.CHINA SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 46.INDIA SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 47.AUSTRALIA SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 48.SOUTH KOREA SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 49.REST OF ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 50.BRAZIL SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 51.SAUDI ARABIA SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 52.SOUTH AFRICA SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 53.REST OF LAMEA SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 54. TOP WINNING STRATEGIES, BY YEAR
FIGURE 55. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 56. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 57.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 58.COMPETITIVE DASHBOARD
FIGURE 59.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 60.10X GENOMICS.: NET SALES ,($MILLION)
FIGURE 61.AGILENT TECHNOLOGIES, INC..: NET SALES ,($MILLION)
FIGURE 62.BECTON, DICKINSON AND COMPANY.: NET SALES ,($MILLION)
FIGURE 63.BIO-RAD LABORATORIES.: NET SALES ,($MILLION)
FIGURE 64.DANAHER CORPORATION(CYTIVA LIFE SCIENCES).: NET SALES ,($MILLION)
FIGURE 65.ILLUMINA, INC..: NET SALES ,($MILLION)
FIGURE 66.BERKLEY LIGHTS INC.: NET SALES ,($MILLION)
FIGURE 67.BGI GENOMICS CO. LTD.: NET SALES ,($MILLION)
FIGURE 68.DIASORIN GROUP (LUMINEX CORPORATION).: NET SALES ,($MILLION)
FIGURE 69.DOLOMITE BIO.: NET SALES ,($MILLION)
FIGURE 70.MERCK KGAA.: NET SALES ,($MILLION)
FIGURE 71.OXFORD NANAOPORE TECHNOLOGIES.: NET SALES ,($MILLION)
FIGURE 72.QIAGEN N.V.: NET SALES ,($MILLION)
FIGURE 73.SARTORIUS AG.: NET SALES ,($MILLION)
FIGURE 74.STANDARD BIOTOOLS (FLUIDIGM CORPORATION).: NET SALES ,($MILLION)
FIGURE 75.TAKARA HOLDINGS INC.: NET SALES ,($MILLION)
FIGURE 76.THERMO FISHER SCIENTIFIC, INC..: NET SALES ,($MILLION)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security